首页> 外文期刊>Clinical and experimental allergy : >Sublingual allergen administration. I. Selective suppression of IgE production in rats by high allergen doses
【24h】

Sublingual allergen administration. I. Selective suppression of IgE production in rats by high allergen doses

机译:舌下含服过敏原给药。I.高过敏原剂量选择性抑制大鼠IgE的产生

获取原文
获取外文期刊封面目录资料

摘要

SummarySublingual administration of a protein allergen to immunologically naïve rats suppressed subsequent allergen‐specific IgE responses. Susceptibility to this form of immunotherapy was genetically determined, with some inbred rat strains displaying immunological tolerance in the IgE antibody class alone, whilst others developed concomitant suppression of IgG. Parallel gastric intubation experiments established that the development of tolerance by sublingual allergen administration proceeded independently of events occurring in the gut resulting from swallowing the allergen. These results are consistent with clinical reports which suggest that the oral mucosa is a potentially useful site for therapeutic modulation of allergic reactivity, and indicate that appropriate animal models can be developed to probe this important question. However, further research is required to determine the relevance of these findings to current sublingual desensitization practic
机译:摘要对免疫学初治大鼠舌下含服蛋白质过敏原可抑制随后的过敏原特异性 IgE 反应。对这种形式的免疫疗法的易感性是由遗传决定的,一些近交系大鼠品系仅在 IgE 抗体类别中表现出免疫耐受性,而另一些则同时出现 IgG 抑制。平行胃插管实验确定,舌下含服过敏原给药的耐受性发展独立于吞咽过敏原导致的肠道中发生的事件。这些结果与临床报告一致,临床报告表明口腔粘膜是治疗调节过敏反应性的潜在有用部位,并表明可以开发适当的动物模型来探索这一重要问题。然而,需要进一步的研究来确定这些发现与当前舌下脱敏实践的相关性

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号